Yousif Capital Management, LLC Cara Therapeutics, Inc. Transaction History

Yousif Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$4.89 - $12.27 $13,203 - $33,129	-2,700 Reduced 9.4%	26,035 $127,000
Q4 2022 Jan 09, 2023	SELL	$8.88 - $12.77 $127,916 - $183,951	-14,405 Reduced 33.39%	28,735 $0
Q3 2022 Nov 04, 2022	BUY	$8.24 - $12.56 $5,471 - $8,339	664 Added 1.56%	43,140 $404,000
Q2 2022 Aug 01, 2022	SELL	$7.45 - $13.84 $21,418 - $39,790	-2,875 Reduced 6.34%	42,476 $388,000
Q1 2022 May 12, 2022	SELL	$9.94 - $12.65 $10,884 - $13,851	-1,095 Reduced 2.36%	45,351 $551,000
Q4 2021 Jan 31, 2022	BUY	$11.99 - $18.14 $556,887 - $842,530	46,446 New	46,446 $566,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Yousif Capital Management, LLC with notifications on news.